Patients diagnosed with chronic granulomatous disease and/or Job's syndrome may yield a reduced detection of galactomannan
AVOID opening the specimen after collection to prevent contamination with fungal spores and/or bacteria present in the environment (transport in sealed tubes).
Gold serum separator (SST) tube
Note: Pour-off specimens and specimens sent in non-sterile containers will be rejected due to the risk of false positive results.
Note: If an aliquoting step cannot be avoided, aliquot within a well maintained biosafety cabinet using sterile technique. Avoid opening the specimen after collection to prevent the environment.
Sterile container
Note: Submissions in non-sterile containers or containers without a secure screw cap will be rejected
Serum:
Refrigerated (unopened) - 5 days
Frozen - 5 months
Freeze/thaw cycle: Stable x4
Ambient - NO
BAL:
Refrigerated (Unopened) - 24 hours
Frozen - 5 months
Freeze/thaw cycle: Stable x4
Ambient - NO
Enzyme immunoassay (EIA)
0.00 - 0.49 Index
Reduced assay sensitivity may occur in patients receiving concomitant antifungal therapy. Penicillium species, Alternaria species, Paecilomyces species, Geotrichum species, and Histoplasma species have demonstrated reactivity with the monoclonal antibodies used in the assay and may, therefore, yield a positive test result.
Positive results in patients with no clinical signs of disease have been reported, especially in young children. Most of these are considered to be false positives. Young children may have a positive assay result due to the presence of galactofuranaase contained in various foods (cereals) and milk. Patients receiving piperacillin/tazobactam or semisynthetic beta-lactamase therapy may have false-positive results. False-positive results may also occur with use of PLASMA-LYTE(TM) for either intravenous hydration or BAL specimen collection.